Pharm. (Prof.) Cyril Odianose Usifoh, the Immediate Past President of the Pharmaceutical Society of Nigeria (PSN), played a pivotal role at the 12th Edition of the Pharmaconex 2025 Technical Conference, held from September 1-3, 2025, at the Egypt International Exhibition Centre, El Moshir Tantawy Axis, New Cairo.

The conference focused on the theme "Investing Pharma: Unlocking Opportunities Across the Middle East and Africa," bringing together industry leaders, experts, exhibitors, innovators, stakeholders and key decision-makers to explore strategic investment opportunities and regional growth within the pharmaceutical sector.

Prof. Usifoh delivered an engaging keynote address during the conference, emphasizing the importance of collaboration and innovation in driving growth in the pharmaceutical industry across the Middle East and Africa. He highlighted the potential of the region in attracting foreign direct investments, leveraging advanced technologies, and fostering partnerships that can enhance healthcare delivery and pharmaceutical developments.

In his address, Prof. Usifoh stressed the need for a comprehensive approach to addressing the challenges faced by the pharmaceutical sector, including regulatory frameworks, market access, and the integration of digital transformation. He called on stakeholders to adopt forward-thinking strategies that align with global best practices to accelerate market growth and address the evolving healthcare needs of the population.

The Pharmaconex 2025 conference served as a vital platform for professionals in the pharmaceutical industry to connect, share insights, and discuss the future of pharmaceutical market growth, digital transformation, and other pertinent topics. Attendees engaged in vibrant discussions about the latest trends and innovations that can shape the future of healthcare in the region.

Throughout the conference, Prof. Usifoh participated actively in panel discussions and networking sessions, exchanging ideas and fostering relationships with fellow industry leaders. His contributions were well-received, and he was lauded for his expertise and vision regarding the future of the pharmaceutical sector in Africa.

“Investing in the pharmaceutical sector is not just about capital; it’s about investing in people, processes, and technologies that result in impactful health outcomes,” Prof. Usifoh remarked, underscoring the theme of the conference.

With the valuable insights shared at Pharmaconex 2025, Professor Cyril Usifoh and other conference participants left with a renewed sense of purpose and commitment to advancing the pharmaceutical landscape in the Middle East and Africa, paving the way for a healthier tomorrow.